SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-044235
Filing Date
2013-09-13
Accepted
2013-09-13 19:14:34
Documents
1
Period of Report
2013-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11073
  Complete submission text file 0001209191-13-044235.txt   12452
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6410 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
MORNEAU MICHAEL (Reporting) CIK: 0001517780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 131097412